University of Cincinnati names graduate school dean

Rose Marie Ward will serve as vice provost and dean of UC's Graduate School

Valerio Ferme, PhD, executive vice president for academic affairs and provost at the University of Cincinnati, today announced the appointment of Rose Marie Ward, PhD, as vice provost and dean of the Graduate School.

Ward, who will begin her new role July 1, 2022, pending approval by the UC Board of Trustees, currently serves as professor of kinesiology, nutrition and health and associate dean of the Graduate School at Miami University in Oxford, Ohio. Ward has extensive experience in graduate education including financial and strategic planning, development of new degree and certificate programs, research, and cross-college and programmatic engagement.

O08721 Rose Marie Ward

Rose Marie Ward, PhD

“Rose Marie is a proven collaborative leader. Her skills and experience working across colleges to address emerging trends within higher education will bolster strategic initiatives to advance the impact of the Graduate School, and importantly foster student success,” says Ferme. “Her passion for innovation, graduate education and for strengthening UC’s diverse and inclusive community is contagious and will be embraced by many.”

Throughout her career Ward has championed and established many graduate student and diversity support programs and services and currently serves as the principal investigator (PI) and Co-PI for three National Science Foundation diversity and inclusion grants. Additionally, Ward’s work has led to increased graduate student research opportunities.

I look forward to the opportunity to come alongside students, staff, and faculty as we boldly imagine what is next in graduate education.

Rose Marie Ward, PhD

Ward says she is thrilled join the UC Bearcat family.  “The Bearcat family's passion for innovation and inclusion makes UC the ideal testbed for transformative experiences and for local and global impact.”

Ward joined Miami University in 2002 and has held several positions including director of the Center for Teaching Excellence, associate dean for graduate studies and interim associate provost and dean for graduate studies. She is a 2021 Miami University honoree for excellence in research, and 2013 recipient of the Greater Cincinnati Consortium of Colleges and Universities Teaching Award. In 2011, she received the National Society of Leadership and Success Excellence in Teaching Award. She has authored numerous book chapters and journal articles in the areas of college student alcohol consumption and campus sexual assault. 

Ward holds a Bachelor of Science degree in psychology and communication from Juniata College and both a master’s and PhD in experimental psychology from the University of Rhode Island.

About UC's Graduate School

The University of Cincinnati Graduate School cultivates the leaders of tomorrow. From groundbreaking research to innovative professional pursuits, we invest in our students and challenge the intellectually curious to pursue what’s Next– in their profession, discipline, and in society at large. The Graduate School administers 350+ graduate degree and certificate programs and serves more than 11,000 graduate students from across the globe.

Related Stories

1

Children exposed to gambling mechanics before they understand money

February 4, 2026

Gambling-style mechanics are becoming a routine part of children’s digital lives, appearing in online games, mobile apps and even sports betting advertisements that surround popular media. University of Cincinnati experts warned in a recent WKRC-TV Local 12 report that long before children understand the value of money, they are learning the emotional highs and lows associated with risk. Online games, such as Roblox and Fortnite, offer fast-paced rewards that can keep children glued to screens.

3

Study: Synthetic protein potentially improves outcomes for certain subgroups following intracerebral hemorrhage

February 4, 2026

The University of Cincinnati’s Joseph Broderick, MD, presented results from the FASTEST trial at the International Stroke Conference, simultaneously published in The Lancet, that found administering a synthetic protein, recombinant Factor VIIa, can reduce bleeding and potentially improve outcomes for certain patients at the highest risk of continued bleeding following an intracerebral hemorrhage.